C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 453/02 (2006.01) A61K 31/5365 (2006.01) A61P 11/06 (2006.01) C07D 519/00 (2006.01)
Patent
CA 2523436
Compounds of formula (I), in salt or zwitterionic form wherein, wherein R1, R2, R3, and R4 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by the muscarinic M3 receptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
Cette invention concerne des composés représentés par la formule (I) sous forme de sel ou de composés zwitterioniques, dans laquelle R?1¿, R?2¿, R?3¿, et R?4¿ ont la signification indiquée dans le descriptif, convenant pour le traitement de manifestations induites par le récepteur muscarinique de type M3. Sont également décrites des compositions pharmaceutiques contenant lesdits composés et une méthode de préparation de ces composés.
Baettig Urs
Bhalay Gurdip
Collingwood Stephen Paul
Cox Brian
Devereux Nicholas James
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Quinuclidine derivatives binding to mucarinic m3 receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinuclidine derivatives binding to mucarinic m3 receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinuclidine derivatives binding to mucarinic m3 receptors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2051461